# CE Marking & EU MDR Compliance: What European Buyers Should Verify

> CE marking under EU MDR is device-specific, not a blanket company certification. A practical guide to what AK Medical's European regulatory status covers and how to verify it.

- URL: https://www.ak-medical-global.com/blog/ce-marking-eu-mdr-compliance
- Published: 2026-09-22
- Author: AK Medical Editorial Team, AK Medical Holdings Limited
- Topics: Regulatory, Company, Procurement, Education

For orthopedic implants, CE marking should not be read as a general "European certification" awarded to a company. Under Regulation (EU) 2017/745 — the Medical Device Regulation (MDR) — CE marking indicates that a specific device has completed the applicable conformity assessment, with the manufacturer taking responsibility for demonstrating compliance. For higher-risk devices, that process requires an independent Notified Body.

This is directly relevant to joint replacement: under MDR Annex VIII, Rule 8, total or partial joint replacement devices are generally classified as **Class III**, the highest-scrutiny category, subject to specific exceptions for certain ancillary components. So the right question isn't "does the company have CE?" — it's **which specific device is CE marked, under which certificate scope, and is that status currently valid?**

## AK Medical's European regulatory footprint

AK Medical holds **CE Mark** certification across its portfolio for the EU/EEA market, alongside its NMPA and FDA authorizations — company disclosures describe CE full quality assurance certification spanning hip systems, knee systems, and 3D-printed interbody fusion devices. That track record reflects genuine, longstanding European regulatory experience.

It should still be read carefully. A historical certificate count doesn't by itself establish current MDR status for every product, because the EU regulatory environment changed substantially with MDR's application and the transition of legacy devices. For any current procurement decision, the reliable chain is: product name → risk classification → regulatory basis → Notified Body → certificate number → certificate scope → current validity → EU Declaration of Conformity → UDI/EUDAMED information.

## Why Class III implants get more scrutiny

Hip and knee implants remain in the body for years under substantial mechanical and biological demand, which is why MDR places total and partial joint replacement in its highest risk class. Class III is a **risk category, not a quality ranking** — it requires a stronger conformity pathway: classification → quality management system → technical documentation → risk management → clinical evaluation → verification and validation → Notified Body assessment → EU Declaration of Conformity → CE marking → postmarket surveillance.

## Clinical evaluation, SSCP, and EUDAMED

MDR requires a clinical evaluation appropriate to the device's characteristics and intended purpose — for Class III and implantable devices, expectations are stronger, though this doesn't automatically mean a new randomized trial for every device; the requirement is that available evidence be sufficient for the specific device's safety, performance, and intended purpose.

For implantable and Class III devices, MDR also generally requires a **Summary of Safety and Clinical Performance (SSCP)** — validated by the Notified Body and made publicly available — giving surgeons and hospital technology committees a structured source for clinical evidence, not just a certificate.

**EUDAMED**, the European Database on Medical Devices, supports transparency across economic operators, devices/UDI, Notified Bodies and certificates, clinical investigations, and vigilance. Non-EU manufacturers, including AK Medical, are also required to maintain an EU Authorised Representative under MDR.

## Legacy MDD certificates aren't the same as MDR certificates

One of the most important issues in European procurement today is the transition from the former MDD framework to MDR. Certain legacy devices may continue under transitional provisions if MDR Article 120 conditions are met, with transitional periods that can extend into 2027–2028 depending on classification. A historical CE certificate does not automatically equal a current MDR certificate — professional users should verify MDR status, or a valid legacy transitional arrangement, together with the relevant Notified Body, certificate number, scope, and expiry date.

## A practical verification path

For any device: confirm the exact product and configuration, MDR classification, applicable CE certificate or lawful transitional status, Notified Body and certificate scope, EU Declaration of Conformity, UDI/EUDAMED records, current IFU and labeling, SSCP where required, and current postmarket support. That turns CE compliance into a verifiable, product-level process rather than a marketing label.

## The bottom line

AK Medical has a documented history of European regulatory activity across its hip, knee, and 3D-printed product lines. For any current commercial decision, the most reliable principle remains simple: **verify the exact product and its current regulatory documentation.**

Browse our [product catalogue](/products) or contact our team for current European regulatory documentation on a specific device.

*This page is intended for general regulatory education and does not constitute legal advice. Product status may vary by device, version, certificate scope, and market. Current EU Declaration of Conformity, CE/MDR certificate, SSCP, IFU, and labeling should be reviewed before procurement, distribution, or clinical use.*